Optima Medical Innovations Corp.
TOKIF
$0.00
$0.000.00%
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Revenue | 1.14M | 950.30K | 1.19M | -1.34M | 1.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.14M | 950.30K | 1.19M | -1.34M | 1.11M |
| Cost of Revenue | 839.90K | 673.40K | 881.60K | -845.00K | 746.60K |
| Gross Profit | 300.80K | 276.90K | 307.40K | -493.00K | 366.30K |
| SG&A Expenses | 339.00K | 136.90K | 568.60K | -1.46M | 507.00K |
| Depreciation & Amortization | 134.40K | 140.20K | 136.10K | 171.40K | 176.10K |
| Other Operating Expenses | -- | -- | -150.80K | -- | -- |
| Total Operating Expenses | 1.31M | 950.60K | 1.44M | -2.10M | 1.46M |
| Operating Income | -172.60K | -300.00 | -246.50K | 766.50K | -349.30K |
| Income Before Tax | -260.80K | 30.10K | -77.40K | -57.20K | -366.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -260.80K | 30.10K | -77.40K | -57.20K | -366.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -260.80K | 30.10K | -77.40K | -57.20K | -366.60K |
| EBIT | -172.60K | -300.00 | -246.50K | 766.50K | -349.30K |
| EBITDA | -57.50K | 119.80K | -130.00K | 908.70K | -198.30K |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.01 | -0.01 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.01 | -0.01 |
| Average Basic Shares Outstanding | 50.65M | 50.65M | 50.65M | 50.58M | 50.23M |
| Average Diluted Shares Outstanding | 50.65M | 50.65M | 50.65M | 50.58M | 50.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
